Company Overview and News


Add EXEL
to your dashboard

Headline News

Endo (ENDP) Loses 35% in a Year: Can It Turn Around in 2018?

1h zacks
Shares of Endo International plc (ENDP - Free Report) have tumbled 35.4% over a year against the industry’s gain of 7.1%. (57-0)

Biotech Daily Digest For January 16th

2h seekingalpha
Biotech is rising in 2018 but still lags other sectors that will see more direct impacts from the recently passed tax legislation. (685-0)

Novartis (NVS) Announces Acceptance of Humira BLA by the FDA

2h zacks
Novartis AG (NVS - Free Report) generic arm, Sandoz announced that the FDA accepted its Biologics License Application (BLA) for the proposed biosimilar of AbbVie, Inc. (ABBV - Free Report) Humira. (205-0)

What Do The Recent Gilead And Celgene Buyouts Foretell?

6h seekingalpha
2017 top pick (Kite Pharma) paid off handsomely via the Gilead acquisition. M&As in the bioscience space are likely to continue into 2018. (119-0)

Glaxo's Influenza Vaccine Gets FDA Nod for Label Expansion

2018-01-15 zacks
GlaxoSmithKline plc (GSK - Free Report) received approval from the FDA’s Center for Biologics Evaluation and Research for the label expansion of influenza vaccine — FluarixQuadrivalent. The vaccine has been approved for infants six months or older.  (59-0)

Prothena (PRTA) Tumbles 18% in a Year: What Lies Ahead?

2018-01-15 zacks
Shares of Prothena Corporation (PRTA - Free Report) lost 18.1% over a year as against the industry’ gain of 3.1%. (61-0)

Roche MS Drug Ocrevus Gets Marketing Authorization in Europe

2018-01-15 zacks
Roche Holdings (RHHBY - Free Report) announced that the European Commission (EC) has granted marketing authorization for multiple sclerosis (MS) drug Ocrevus. (122-0)

Global Blood Therapeutics: What The Recent FDA Breakthrough Therapy Designation For Voxelotor Entails

2018-01-14 seekingalpha
Share price continues to move North after the FDA granted voxelotor the Breakthrough Therapy Designation (“BTD”). (68-0)

Aradigm's Bronchiectasis Candidate Has Negative FDA Vote

2018-01-12 zacks
Aradigm Corporation (ARDM - Free Report) announced that the FDA’s Antimicrobial Drugs Advisory Committee has voted against the approval (in the ratio of 12:3) of its lead candidate, Linhaliq (a mixture of liposome encapsulated and unencapsulated ciprofloxacin). Aradigm is looking to get Linhaliq approved for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) patients suffering chronic lung infections with pseudomonas aeruginosa. (90-0)

Perrigo (PRGO) Hits 52-Week High: What's Driving the Stock?

2018-01-12 zacks
Shares of Perrigo Company plc (PRGO - Free Report) hit a new 52-week high of $92.16 on Jan 11, just a few days after the company announced the appointment of its new chief executive officer (CEO), Uwe Rohrhoff. The stock eventually closed at $91.99. (40-0)

The Zacks Analyst Blog Highlights: Celgene, Amgen, Exelixis, Alexion and Vertex

2018-01-12 zacks
Chicago, IL – January 12, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Celgene, Inc. (CELG - Free Report) , Amgen, Inc. (AMGN - Free Report) , Exelixis, Inc. (EXEL - Free Report) , Alexion Pharmaceuticals, Inc. (344-0)

Lilly's Elanco/Aratana's Veterinary Medicine Gets EU Nod

2018-01-12 zacks
Eli Lilly and Company's (LLY - Free Report) animal health subsidiary, Elanco, and partner Aratana Therapeutics, Inc. (PETX - Free Report) have together announced that their veterinary medicine, Galliprant (grapiprant tablets), has been granted a marketing authorization in the EU for the treatment of pain associated with mild to moderate osteoarthritis (OA) in dogs. (71-0)

Endo (ENDP) Gets Subpoena From Florida for Opioid Misuse

2018-01-12 zacks
Endo International plc (ENDP - Free Report) announced that its subsidiary, Endo Pharmaceuticals Inc. (EPI), received a grand jury subpoena from the United States Attorney's Office for the Southern District of Florida seeking documents and information relating to products containing opioid painkiller oxymorphone. (61-0)

Atara Biotherapeutics: What The FDA Clearance For ATA-188 Phase 1 Study At U.S. Sites Entails?

2018-01-12 seekingalpha
Unique CAR-Ts platform is powering an enriched pipeline. The agency also gave clearance to initiate ATA-188 phase 1 study in US sites. (75-0)

Atara Biotherapeutics: What The FDA Clearance For ATA-188 Phase 1 Study At US Sites Entails?

2018-01-12 seekingalpha
Unique CAR-Ts platform is powering an enriched pipeline. The agency also gave clearance to initiate ATA-188 phase 1 study in US sites. (75-1)

CUSIP: 30161Q104